Diasia Biomedical is founded. The Instrument production workshop is established.

The reagent production workshop is established. Full-automatic CLIA-ELISA analyzer is first developed successfully.

The first domestic biochemical POCT-Ruice® Homogeneous Biochemical Analyzer was approved for registration

The automatic pathological staining machine is developed. It combines “Immunocytochemistry” “Immunohistochemistry” and “Fluorescence in situ hybridization”. It’s our solo core technology.

About 100 kinds of Immunohistochemistry special Ruice reagent has been approved. Diasia is formally enter into the blood transfusion system.

To help the world fight against the epidemic, the medical mask production line has been established. It has entered in the white lists of export and passed ISO13485 quality system identification. It is also obtained the CE & TUV certifications.

Diasia biomedical sets sails on a new journey and forward to a brilliant future.